Recruiting

Serum Markers

Sponsor:

Stanford University

Code:

NCT00349830

Conditions

Carcinomas (Including Squamous Cell and Adenocarcinoma)

Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

blood draw

Study Details

Brief summary:

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Conditions

Carcinomas (Including Squamous Cell and Adenocarcinoma)

Neoplasms

Study ID

NCT00349830

Start date

Jan, 2002

Status verified date

Feb, 2026

Completion date

Jan, 2032

Anticipated

Primary completion date

Jan, 2032

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

1. Age > or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
2. Prior diagnosis of cancer or suspected of having cancer
3. Karnofsky performance status of greater than 70
4. Standard pretreatment evaluation
5. Signed Stanford University Human Subjects Committee consent

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Interventions

blood draw

Primary outcome measure

  • Biomarkers for disease [ Time Frame: Day one ]

Central Contacts and Locations

Central contacts

gitrialeligibility@stanford.edu gitrialeligibility@stanford.edu

650-498-7757gitrialeligibility@stanford.edu

gitrialeligibility@stanford.edu

650-498-7757gitrialeligibility@stanford.edu

Locations

Stanford University School of Medicine

Recruiting

Stanford, California, United States, 94305

Contacts

Principal Investigator:

Maximilian Diehn

More Information

Sponsor

Stanford University

Last update posted

Feb 10, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stanford University on 2026-02-10.